Cell analysis system makes first discovery

Professor Itai Yanai of Israel’s Technion developed the CEL-Seq cell analysis method in 2012, identifying the on-off status of each of the 20,000 genes in a cell.  It has just been used to determine embryonic development sequences and could help in understanding how cancer develops.

Breakthrough in development of artificial retinas

Scientists at the Hebrew University of Jerusalem and Tel Aviv University have developed a wireless, light-sensitive, flexible implantable film that mimics the function of the photosensitive cells in the retina. It could potentially form part of a device to replace a damaged retina.

Generic blood pressure treatment

Israel’s Teva has launched a generic version of Exforge HCT – a popular treatment of high blood pressure.  Teva’s generic products save money for patients and health services.

Life expectancy rises again

In Israel in 2013, men had an average life expectancy of 80.3 years while women had 83.9 – an increase of nearly five months for men and three months for women in comparison to 2012.

50,000 wear Israeli remedial shoes

Israel’s AposTherapy has developed a treatment for knee and back pain using unique individually calibrated shoes.  AposTherapy currently treats 50,000 patients and has just raised $15 million to help expand its business in the US market.

New test for foreign matter in lungs

(Thanks to San Diego Jewish World) Scientists at Tel Aviv University have developed a new technique for detecting hazardous particles in the lungs.  The test can be used in emergencies such as fire rescues or as a warning of high pollution levels.

New cancer center is a communal success

(Thanks to Stuart) The Emek Medical Center in Afula, Israel is one of many successful stories showing how ethnic groups in Israel can successfully work side by side.  Jews, Muslims, Christians and Druze raised funds together for a new cancer center, via an inspiring radio campaign.

Israeli MRI detects brain damage earlier

Researchers at Israel’s Ben Gurion University’s Brain Imaging Research Center have developed a method that can detect damage to the brain much earlier than previously thought.  Detection, soon after a trauma, means that the damage might still be reversible.

Progress in treatment of Celiac disease

Back in Feb 2012 I reported good pre-clinical trials of Israeli biotech BioLineRX’s BL-7010 co-polymer for the treatment of celiac disease, for which there is currently no cure or formal treatment. BioLineRX has now announced successful final results from its Phase 1/2 study of BL-7010.

Wiping out parasitic worm infections

Ben Gurion University Professor Zvi Bentwich has received a Grand Challenges in Global Health grant from the Bill & Melinda Gates Foundation for his project in Ethiopia to wipe out parasitic worm infections. Clean water and sanitation facilities and health education are being provided.